Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment

Table 2 Investigation results in patients with diabetic muscle infarction in the setting of end-stage renal disease and a cohort from Horton et al’s systematic review

	Present review		Findings from Horton et al[2]
	Number of patients who had the investigation	n (%)	n/n (%)
Leucocytosis (WCC > 11.0 × 109 cells/L)	35	11 (31.4)	48/112 (42.5)
Leucopenia (WCC < 4.0 × 109 cells/L)	35	1 (2.9)	-
Elevated CRP (> 10 mg/L)	11	9 (81.8)	27/30 (90.0)
Elevated ESR (> 20 mm/h)	8	9 (88.9)	50/60 (83.3)
Elevated creatine kinase (> 150 IU/L for females; > 250 IU/L for males)	34	17 (50.0)	31/98 (31.6)
HbA1c > 7.0%, n (%)	18	11 (61.1)	-
MRI findings		35 (85.4)
Muscle enlargement	35	33 (94.2)	-
Muscle edema	35	30 (85.7)	76.8
Subcutaneous edema	35	17 (43.6)	-
Muscle biopsy findings		16 (39.0)
Muscle necrosis	16	16 (100)	-
Inflammatory cell infiltration	16	14 (87.5)	-
Muscle fibre regeneration	16	7 (43.8)	-

CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; MRI: Magnetic resonance imaging; WCC: White cell count.